Industrial Internet Consortium Announces First Security Claims Evaluation Testbed
The Industrial Internet Consortium ® (IIC) announces its first security assessment-focused testbed: the Security Claims Evaluation Testbed. IIC member organizations UL, Xilinx, Aicas and PrismTech are collaborating on the project to provide an open and easily configurable cybersecurity platform for evaluation of endpoint, gateway, and other networked components’ security capabilities. Data sources can include industrial, automotive, medical and other related endpoints requested for secure operation analysis.
IIC members will be able to connect their equipment to the testbed to evaluate the security of their devices within two different scenarios: individually on a device level, or with a system of other endpoints, gateways, etc. The options include exploration of methodology and collection of evidence to demonstrate the system operational security processes supporting the key characteristics of the system relative to evaluation of the participant’s claims. Additionally, the testbed enables the evaluation of those critical areas of an architecture pattern that need to be secured as outlined in the Industrial Internet Reference Architecture Technical Report.
Understanding the security of devices very early in product development can minimize delays for product launch. The testbed aims to enable manufacturers to improve the security posture of their products and verify alignment to the upcoming IIC Security Framework Technical Report prior to product launch to help accelerate time to market.
The testbed will be rolled out in three stages, with the first being initial deployment in a lab environment and the second in a micro-factory environment. The third phase will be determined by the growth of the testbed. The security testbed’s phased release approach provides a unique learning opportunity to evaluate security vulnerabilities at a device level as well as a system level prior to large scale deployment across many key applications driving the Industrial Internet of Things (IIoT) / Industry 4.0.
“Working to help assure the security of the Industrial Internet is a logical extension of UL’s work to support safer environments globally,” said Jeff Smidt, Vice President and General Manager of UL’s energy & power technologies division. “By offering the first IIC-approved security evaluation testbed to IIC members and the broader IIoT community, we are meeting the manufacturers’ need to address their products’ security profile early on in the product development cycle, thus enabling more efficient product rollout processes.”
“Xilinx is committed to providing the Industrial IoT industry with our latest All Programmable SoC technologies that focus on achieving the highest levels of anti-tamper, information assurance and trust capabilities,” said Lawrence Getman, Vice President of Corporate and Strategic Marketing at Xilinx. “Xilinx’s technology is at the heart of the Security Claims Evaluation testbed. By leveraging the highly flexible and configurable nature that our Programmable SoC devices provide, we enable a broad spectrum of use cases that further enhance the participants’ security claim assessments.”
“Aicas helps realize the Industrial IoT industry with secure, scalable, dynamic component-based composable, standards-based, deterministic hard real-time capable, multi-language software platforms,” said David Beberman, Chief Sales and Marketing Officer at Aicas. “Aicas’ toolchain and platform Java bytecode based technology and secure messaging technology enables component level installation and runtime authentication, authorization and IP protection for the Security Claims Evaluation testbed, and extends it with authentication, authorization and privacy to the cloud.”
“PrismTech develops secure, high performance, real-time end-to-end, data connectivity solutions for the Industrial IoT based on the OMG’s Data Distribution Service for Real-time Systems standard,” said Lawrence Ross, CEO, PrismTech. “Our technology will provide the Security Claims Evaluation Testbed with a flexible and secure Edge to Cloud data backbone that can support a broad range of participants’ security claims assessments.”
Partners Contributing to the Security Claims Evaluation Testbed:
The testbed will leverage several technologies from non-IIC constituents including: secure intelligent gateway and networking IPs providing endpoint to the cloud communication from SoC-e (System-on-Chip engineering S.L.), overall testbed monitoring with real-time analytics from Juxt.io, endpoint monitoring from PFP Cybersecurity, and programmable SOC Platforms and IP from iVeia.
To learn more about this testbed, visit www.iiconsortium.org/security-claims.
About Industrial Internet Consortium
The Industrial Internet Consortium is an open membership organization, with over 230 members to date, formed to accelerate the development, adoption and wide-spread use of interconnected machines and devices, intelligent analytics and people at work. Founded by AT&T, Cisco, General Electric, IBM and Intel in March 2014, the IIC catalyzes and coordinates the priorities and enabling technologies of the Industrial Internet. For more information, visit www.iiconsortium.org .
UL is a premier global independent safety science company that has championed progress for more than 120 years. Its nearly 11,000 professionals are guided by the UL mission to promote safe working and living environments for all people via two distinct entities: Underwriters Laboratories Inc., a 501(c)3 public charity, and UL, LLC. UL uses research and standards to continually advance and meet ever-evolving safety needs. We partner with businesses, manufacturers, trade associations and international regulatory authorities to bring solutions to a more complex global supply chain. For more information, visit www.UL.com .
Xilinx is the leading provider of All Programmable FPGAs, SoCs, MPSoCs, and 3D ICs. Xilinx uniquely enables applications that are both software defined and hardware optimized – powering industry advancements in Cloud Computing, SDN/NFV, Video/Vision, Industrial IoT, and 5G Wireless. For more information, visit www.xilinx.com .
aicas is a leading producer of Java development and analysis tools for real-time and embedded systems. The company was founded in 2001, headquartered in Karlsruhe, Germany.
JamaicaVM is aicas' flagship product, a hard real-time Java virtual machine with fully preemptable, deterministic garbage collection. JamaicaVM is optimized for critical systems such as real-time control, network communication, and human-machine interfaces (HMI). JamaicaVM is widely used in the industrial automation, military and aerospace, automotive, medical, and financial markets. For more information, visit www.aicas.com .
PrismTech’s customers deliver systems for the Internet of Things, the Industrial Internet and advanced wireless communications. PrismTech supplies the data connectivity solutions, tools and professional services they need to build systems with the required: platform coverage, performance, scalability, efficiency, flexibility and robustness.
PrismTech’s customers service many market sectors, including: industrial automation, energy, healthcare, transportation, smart cities, aerospace and defense. For additional information about PrismTech, visit www.prismtech.com .
© The Industrial Internet Consortium logo is a registered trademark of Object Management Group®. Other logos, products and company names referenced in this document are property of their respective companies.
Industrial Internet Consortium
Kathy Walsh, +1 781-444-0404
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 11:00 | Pressemelding
Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines
Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 08:10 | Pressemelding
Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest
Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 15:13 | Pressemelding
Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,
Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 14:00 | Pressemelding
Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With
Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 13:41 | Pressemelding
Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel
Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 12:00 | Pressemelding
Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i